Evaluation of clinical, laboratory and histopathological findings, and treatment outcomes of patients with urticarial vasculitis: a single-center retrospective study

Background Urticarial vasculitis (UV) is a rare small-vessel vasculitis characterized by wheal-like lesions persisting for more than 24 hours.Objective To evaluate the demographic, clinical, laboratory, and treatment characteristics of patients with UV.Materials and Methods We retrospectively evaluated adults with clinically and histopathologically confirmed UV at a tertiary care hospital between January 2014 and August 2024.Results Ninety-three patients (72.0% women; mean age, 44.3 ± 19.5 years) were included. Mean disease duration was 36.04 ± 51.9 months. Angioedema occurred in 20.4%. The most common extracutaneous findings were renal/urinary abnormalities (19.4%), arthralgia (6.5%), and gastrointestinal symptoms (6.5%). Infections and drugs were the most common potential associated factors. Elevated total IgE was detected in 45.2%, ANA positivity in 25.8%, anti-TPO IgG positivity in 10.8%, and hypocomplementemia in 8.2% of tested patients. Oral H1 antihistamines (OAH), systemic corticosteroids, omalizumab, and other systemic agents were used in 90 (96.8%), 33 (35.5%), 47 (50.5%), and 23 (24.7%) patients, respectively. Clinical response rates were 40.0% (36/90), 39.4% (13/33), 68.1% (32/47), and 30.4% (7/23), respectively.Conclusion Omalizumab may be an alternative treatment for predominantly cutaneous UV. Although the observed response proportion was highest with omalizumab, comparative effectiveness cannot be established because of the retrospective design and potential confounding by indication. Prospective controlled studies are warranted.

Authors

Institutions

Publication Details

Journal
Cutaneous and Ocular Toxicology
Published
2026-11-21
DOI
https://doi.org/10.1080/15569527.2026.2756313
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of clinical, laboratory and histopathological findings, and treatment outcomes of patients with urticarial vasculitis: a single-center retrospective study

Beyhan Cengiz Özyurt, Tubanur Çetinarslan, Aylin Türel Ermertcan, Peyker Temız et al.
Cutaneous and Ocular Toxicology
Vasculitis and related conditions
article

Evaluation of clinical, laboratory and histopathological findings, and treatment outcomes of patients with urticarial vasculitis: a single-center retrospective study

Beyhan Cengiz Özyurt, Tubanur Çetinarslan, Aylin Türel Ermertcan, Peyker Temız, Göksu Dalgıç
article en

Abstract

Background Urticarial vasculitis (UV) is a rare small-vessel vasculitis characterized by wheal-like lesions persisting for more than 24 hours.Objective To evaluate the demographic, clinical, laboratory, and treatment characteristics of patients with UV.Materials and Methods We retrospectively evaluated adults with clinically and histopathologically confirmed UV at a tertiary care hospital between January 2014 and August 2024.Results Ninety-three patients (72.0% women; mean age, 44.3 ± 19.5 years) were included. Mean disease duration was 36.04 ± 51.9 months. Angioedema occurred in 20.4%. The most common extracutaneous findings were renal/urinary abnormalities (19.4%), arthralgia (6.5%), and gastrointestinal symptoms (6.5%). Infections and drugs were the most common potential associated factors. Elevated total IgE was detected in 45.2%, ANA positivity in 25.8%, anti-TPO IgG positivity in 10.8%, and hypocomplementemia in 8.2% of tested patients. Oral H1 antihistamines (OAH), systemic corticosteroids, omalizumab, and other systemic agents were used in 90 (96.8%), 33 (35.5%), 47 (50.5%), and 23 (24.7%) patients, respectively. Clinical response rates were 40.0% (36/90), 39.4% (13/33), 68.1% (32/47), and 30.4% (7/23), respectively.Conclusion Omalizumab may be an alternative treatment for predominantly cutaneous UV. Although the observed response proportion was highest with omalizumab, comparative effectiveness cannot be established because of the retrospective design and potential confounding by indication. Prospective controlled studies are warranted.

Cutaneous and Ocular Toxicology
Manisa Celal Bayar University (TR)
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Evaluation of clinical, laboratory and histopathological findings, and treatment outcomes of patients with urticarial vasculitis: a single-center retrospective study — Beyhan Cengiz Özyurt, Tubanur Çetinarslan, et al. · Cutaneous and Ocular Toxicology (2026) | TGRS Research Map | TGRS